ARTICLE | Finance
IPOs on and off
Cancer vaccine play NewLink readies IPO, while Cutanea pulls its offering
October 31, 2011 7:00 AM UTC
Cancer vaccine company NewLink Genetics Corp. updated IPO terms, while dermatology play Cutanea Life Sciences Inc. officially pulled its IPO, which dates to 2010.
NewLink hopes to sell 5.5 million shares at $10-$12. An $11 price would raise $60.5 million and value the company at $198.2 million...